D C Louie - Concepedia

Author

D C Louie

Memorial Sloan Kettering Cancer Center

Also Known As

D C Louie, D Louie, D. Louie, D.C. Louie, Darren Louie

Publications

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center University of Pennsylvania Columbia University

About

D C Louie is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	439
2	Cell Biology	6	6	403
3	Natural Sciences	1	1	13
4	Allergy	1	1	20
5	Cellular Physiology	1	1	13

D C Louie

Publications

943

Citations

H-Index

Page 1

	Year	Citations
6q deletions define distinct clinico-pathologic subsets of non- Hodgkin's lymphoma Kenneth Offit, NZ Parsa, Gianluca Gaïdano, Blood	1993	186
Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Richard M. Siegel, Makoto Katsumata, Toshiyuki Miyashita, Proceedings of the National Academy of Sciences Lymphocyte DevelopmentT-regulatory CellApoptosisImmunologyCell Death	1992	179
Non-Hodgkin lymphoma of the breast: imaging characteristics and correlation with histopathologic findings. Laura Liberman, Catherine S. Giess, D. David Dershaw, Radiology	1994	152
Differential effects of Bcl-2 on T and B cells in transgenic mice. Makoto Katsumata, Richard M. Siegel, D C Louie, Proceedings of the National Academy of Sciences Lymphocyte DevelopmentTransgene ExpressionAdaptive Immune SystemT-regulatory CellImmunology	1992	135
Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice. João F. Lacerda, Marc Ladanyi, D C Louie, The Journal of Experimental Medicine	1996	95
Absence of t(14;18) major and minor breakpoints and of Bcl-2 protein overproduction in Reed-Sternberg cells of Hodgkin's disease. D C Louie, J A Kant, J. Brooks Jackson, PubMed	1991	50
Nonsyntenic Amplification of MYC with CDK4 and MDM2 in a Malignant Mixed Tumor of Salivary Gland Pulivarthi H. Rao, V.V.V.S. Murty, D C Louie, Cancer Genetics and Cytogenetics Tumor BiologyTumoral PathologyMalignant DiseaseNonsyntenic AmplificationPathology	1998	40
Suppressor Cells in Vitro: Differential Effects of Indomethacin and Related Compounds John D. Kemp, D C Louie, Jerome A. Mattingly, Journal of Immunopharmacology Arachidonic Acid MetabolismAntibiotic AdjuvantImmunologyImmune RegulationImmunologic Mechanism	1980	20
BCL-6 in diffuse large-cell lymphomas. Riccardo Dalla‐Favera, Bishan Ye, Giorgio Cattoretti, PubMed Hematological MalignancyLymphoid NeoplasiaMedicineHematologyImmunology	1996	19
The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: a sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide C. Portlock, Jing Qin, P. Schaindlin, Annals of Oncology Lymphoid NeoplasiaSequential Dose-denseAggressive Non-hodgkinMedicineMalignant Blood Disorder	2004	17

Page 1